Patrick English 已转推

GLP-1RA cardiovascular protection is duration dependent.
In >330k people with T2D:
🫀 Risk reduction strongest with continuous 3-year use (IRR 0.82)
⏳ Short use (<1.5 yrs) → little CV benefit
⛔ Interruptions or discontinuation → progressively ↑ MACE risk
Consistency matters. Long-term treatment drives cardiovascular protection.
pmc.ncbi.nlm.nih.gov/articles/PMC13…

English






















